ArticleBritish journal of cancer2011

An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells.

M Yashiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.